68Ga-PSMA-11 and18F-AlF-PSMA-11 PET/CT seem to be clinically equivalent imaging techniques for the assessment of primary intermediate-/high-risk PCa with great potential for the detection of metastatic spread that would impact patient management. The gene discussed is FOLH1; the disease is posterior cortical atrophy.